Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_assertion type Assertion NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_head.
- NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_assertion description "[There was good correlation between expression of the functional antagonists, BCL-2/BCL-X and BAX, suggesting that changes in the BCL-2+BCL-X/BAX ratio are not responsible for the differential response of glioma patients to chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_provenance.
- NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_assertion evidence source_evidence_literature NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_provenance.
- NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_assertion SIO_000772 9562325 NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_provenance.
- NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_assertion wasDerivedFrom befree-20140225 NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_provenance.
- NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_assertion wasGeneratedBy ECO_0000203 NP746125.RAXOek5qYTFCrDJ67gmU_wPWec2mPGgH9QALXdD-qipAU130_provenance.